Posted inComunicati
Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington’s Disease to the United States, Canada and the United Kingdom
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE More than ten countries and more than twenty sites are…









